Announcements Trials
Browse Landscape

Status

Completed 21Recruiting 17Unknown 15Terminated 6Not yet recruiting 5Active not recruiting 3

Sponsor Class

OTHER 3

Study Type

Interventional 28Observational 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Breast Neoplasms 144Neoplasms 130Prostatic Neoplasms 81Carcinoma, Non-Small-Cell Lung 79Lung Neoplasms 65Colorectal Neoplasms 46Carcinoma, Hepatocellular 37Stomach Neoplasms 33Multiple Myeloma 28Brain Neoplasms 28Uterine Cervical Neoplasms 27Melanoma 26Pancreatic Neoplasms 25Rectal Neoplasms 24Ovarian Neoplasms 24Head and Neck Neoplasms 23Colonic Neoplasms 23Urinary Bladder Neoplasms 22Hematologic Neoplasms 22Neoplasm Metastasis 21Esophageal Neoplasms 20Carcinoma, Renal Cell 20Leukemia, Myeloid, Acute 19Precursor Cell Lymphoblastic Leukemia-Lymphoma 17Endometrial Neoplasms 17Recurrence 15Cardiovascular Diseases 15Thyroid Neoplasms 14Lymphoma 14Liver Neoplasms 14

Interventions

pembrolizumab 1gemcitabine-oxaliplatin regimen 1Nivolumab 1Immune Checkpoint Inhibitors 1High-Throughput Nucleotide Sequencing 1Gemcitabine 1Drug Therapy 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Active not recruiting × Observational × Biliary Tract Neoplasms × Clear all
NCT05036486 2026-01-20

The Registry of Genetic Alterations of Taiwan Biliary Tract Cancer

National Health Research Institutes, Taiwan

Active not recruiting
480 enrolled
Gastrointestinal

Biliary Tract Neoplasms

NCT06975917 2025-05-16

TOG-SAFRADJU

Ankara University

Active not recruiting
600 enrolled
Gastrointestinal

Biliary Tract Neoplasms

NCT03695952 2025-01-28

A Prospective Cohort Study of Patients with Hepatobiliary Cancer Treated with Immune Checkpoint Inhibitors

Asan Medical Center

Active not recruiting
100 enrolled
Gastrointestinal

Biliary Tract Neoplasms, Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡